The Role of Lipid Metabolism in Dyslipidemias and Atherosclerosis

Area of Science:

• Cardiovascular Medicine
• Pathophysiology
• Translational Research

Background:

• Atherosclerotic cardiovascular disease (ASCVD) is a significant global health challenge, contributing substantially to morbidity and mortality.
• Despite advancements in treatment, ASCVD persists as the primary cause of death worldwide.
• Understanding the complex mechanisms of ASCVD is crucial for developing effective interventions.

Discussion:

• Current therapeutic strategies for ASCVD have shown progress but are insufficient to eliminate its impact.
• Further research is needed to explore novel pathways and targets for managing atherosclerotic plaque progression.
• Integrating multi-omics data may provide deeper insights into individual patient risk and treatment response.

Key Insights:

• ASCVD represents a major global health burden, underscoring the urgent need for improved prevention and treatment.
• Despite therapeutic progress, mortality from ASCVD remains high, necessitating innovative approaches.
• The multifaceted nature of atherosclerosis requires a comprehensive understanding of its underlying biological processes.

Outlook:

• Future research should focus on personalized medicine approaches to ASCVD treatment.
• Exploring novel therapeutic targets, such as those involved in inflammation and lipid metabolism, is essential.
• Long-term studies are required to evaluate the efficacy and safety of emerging treatments for ASCVD.